Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Headache, Migraine, Pain
Clinical narrative: body aches; HA; chills; arm pain; severe migraines; all hair fell out; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Sep2021 14:00 (Lot number: 301358A) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "HTN" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "allergy induces asthma" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "migraines" (unspecified if ongoing); "alopecia areata" (unspecified if ongoing). Concomitant medication(s) included: LABETALOL; HYDROCHLOROTHIAZIDE; LEXAPRO; VYVANSE. Past drug history included: Wellbutrin, reaction(s): "Allergy"; Ceftin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: F13246, Location of injection: Arm Left, Vaccine Administration Time: 07:30 AM), administration date: 11Jan2021, when the patient was 44 years old, for COVID-19 Immunization, reaction(s): "Body aches", "HA", "Chills", "Arm pain", "Severe migraines", "significant worsening of alopecia"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EK5730, Location of injection: Arm Left, Vaccine Administration Time: 07:30 AM), administration date: 18Dec2020, when the patient was 44 years old, for COVID-19 Immunization, reaction(s): "Body aches", "HA", "Chills", "Arm pain", "Severe migraines", "Alopecia". The following information was reported: PAIN (non-serious) with onset 2021, outcome "unknown", described as "body aches"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "HA"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "chills"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "arm pain"; MIGRAINE (non-serious) with onset 2021, outcome "recovered" (2021), described as "severe migraines"; ALOPECIA (non-serious) with onset 2021, outcome "unknown", described as "all hair fell out". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, headache, chills, pain in extremity, migraine, alopecia.  Additional information: Known allergies to Wellbutrin, Ceftin. Other medical history included HTN, depression, anxiety, allergy induces asthma, endometriosis, migraines, alopecia areata. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications in two weeks included Labetalol, Hydrochlorothiazide, Lexapro and Vyvanse. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has been tested for COVID-19. Seriousness criteria was reported as non-serious. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received Spironolactone as treatment for the events.  No follow-up attempts are possible. No further information is expected.